Healthtech
Q3 202418.07.2024

Drug discovery (Q3 2024)

Picture of Kai Nicol-Schwarz

Kai Nicol-Schwarz

at Sifted

Developing drugs is a very long and expensive process. It can take between 10 and 15 years and cost more than $1bn to bring one to market. It’s also hit and miss — with the latter doing most of the heavy lifting. 90% of drugs that make it to human trials — the final stage before approval — fail.

But increasingly startups are looking to speed up the process using new tech like proprietary machine learning algorithms and generative AI. While some are looking to develop their own drug candidates, others are building tools to be used by pharma companies and other biotechs.

For startups, there are reasons to be cheerful. AI and ML present a “huge opportunity” for tech companies to solve problems in the drug discovery space, one investor tells Sifted. Another says the approaching “patent cliff” — which will see several revenue-driving drug patents expire — is an “unprecedented opportunity” for startups as pharma companies look to bolster drug pipelines. Others say they’ve noticed lead times to sell into pharma drop since pre-Covid times.

Positive moves — but it’s still early days. While there are some AI-developed drugs in clinical trials, none have yet made it to market. With or without startups — drug discovery is a long game. Investors say major AI-driven advances in the drug discovery process will likely come in the next decade, rather than the next few years. But, if VC confidence in the sector holds, there’s every chance startups could play an increasingly key role in the sector going forward.

20 startups to watch

  • CHARM Therapeutics logo

    Sifted score

    9.13
    -

    CHARM Therapeutics

    3D deep learning for undruggable diseases.

    • Strong investor(s)
    • Serial founder(s)

    • Year founded

      2021

    • HQ

      London, United Kingdom

    • Latest round

      Early VC
      €18.2m / Apr 2023

    • Total funding

      €75.1m

    View company profile
  • Aqemia logo

    Sifted score

    9.02
    -

    Aqemia

    • Strong investor(s)
    • Serial founder(s)
    • Hiring

    • Year founded

      2019

    • HQ

      Paris, France

    • Latest round

      Series A
      €30m / Jan 2024

    • Total funding

      €70.9m

    View company profile
  • Chemify logo

    Sifted score

    8.08
    -

    Chemify

    • Strong investor(s)
    • Serial founder(s)
    • Hiring

    • Year founded

      2022

    • HQ

      Glasgow, United-Kingdom

    • Latest round

      Series A
      €39.8m / Aug 2023

    • Total funding

      €39.8m

    View company profile
  • Abzu logo

    Sifted score

    7.98
    -

    Abzu

    Explainable AI for pharmaceutical research.

    • Strong investor(s)
    • Serial founder(s)

    • Year founded

      2018

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      €2.5m / Jun 2022

    • Total funding

      €10.4m

    View company profile
  • Kvantify logo

    Sifted score

    7.97
    -

    Kvantify

    • Strong investor(s)
    • Serial founder(s)

    • Year founded

      2022

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      €2m / Oct 2023

    • Total funding

      €9m

    View company profile

Related Briefings

Related articles

Revolut and TravelPerk backers warn of market volatility in wake of Trump tariffs
Venture CapitalNews

April 24, 2025

Revolut and TravelPerk backers warn of market volatility in wake of Trump tariffs

By Kai Nicol-Schwarz and Mimi Billing
European crypto firm RockawayX closes $125m fund amid renewed interest in digital assets
Venture CapitalNews

April 24, 2025

European crypto firm RockawayX closes $125m fund amid renewed interest in digital assets

By Tom Matsuda
Revolut reports £1bn in profits as it plots UK banking service rollout
FintechNews

April 24, 2025

Revolut reports £1bn in profits as it plots UK banking service rollout

By Tom Matsuda
Novo Holdings and EIFO invest €48m in Swedish HealthCap's latest fund to strengthen Nordic healthtech
Venture CapitalNews

April 24, 2025

Novo Holdings and EIFO invest €48m in Swedish HealthCap's latest fund to strengthen Nordic healthtech

By Mimi Billing
From procurement to finance: How to pick the right business service provider
Startup LifeAnalysis

April 24, 2025

From procurement to finance: How to pick the right business service provider

From procurement to finance: How to pick the right business service provider
Sponsored by Liberty Blume
The most active VCs and CVCs in Europe in Q1
Venture CapitalAnalysis

April 24, 2025

The most active VCs and CVCs in Europe in Q1

A full breakdown of the quarter’s busiest investors

By Éanna Kelly and Hessa Alabbas
Pro
Black Forest Labs: Europe’s most-hyped — and elusive — startup?
DeeptechAnalysis

April 24, 2025

Black Forest Labs: Europe’s most-hyped — and elusive — startup?

Black Forest Labs: Europe’s most-hyped — and elusive — startup?
By Freya Pratty and Miriam Partington
How Europe can truly lead in quantum
DeeptechOpinion

April 24, 2025

How Europe can truly lead in quantum

Steve Brierley, CEO of Riverlane.
By Steve Brierley
Zopa Bank doubles profits with second year in the green
FintechNews

April 24, 2025

Zopa Bank doubles profits with second year in the green

The company is the latest European neobank to enjoy a run of profitability

By Tom Matsuda
Berlin-based Noxtua raises over €80m Series B to build ‘sovereign’ legal AI
DeeptechNews

April 23, 2025

Berlin-based Noxtua raises over €80m Series B to build ‘sovereign’ legal AI

By Miriam Partington
Exclusive: Kindred Capital backs AI agents startup Cakewalk in $7.5m seed round
DeeptechNews

April 23, 2025

Exclusive: Kindred Capital backs AI agents startup Cakewalk in $7.5m seed round

By Miriam Partington
Early-stage VC Kompas raises €150m for second fund
Venture CapitalNews

April 23, 2025

Early-stage VC Kompas raises €150m for second fund

The VC will invest in industrial tech across Europe, the US and Israel

By Miriam Partington
Bending Spoons CEO Luca Ferrari: ‘We're trying to build one of the most successful companies of all time’
The Big InterviewInterview

April 23, 2025

Bending Spoons CEO Luca Ferrari: ‘We're trying to build one of the most successful companies of all time’

Bending Spoons CEO and cofounder Luca Ferrari.
By Amy Lewin
Pro
Exclusive: German deeptech VC First Momentum raises €35m fund to back energy, automation and AI
Venture CapitalNews

April 23, 2025

Exclusive: German deeptech VC First Momentum raises €35m fund to back energy, automation and AI

By Anne Sraders
Exclusive: Secretive VC firm Hedosophia raises over $200m for secondaries fund, sources say
Venture CapitalNews

April 22, 2025

Exclusive: Secretive VC firm Hedosophia raises over $200m for secondaries fund, sources say

By Kai Nicol-Schwarz
The 10 most active corporate investors in Europe in 2024
Venture CapitalAnalysis

April 22, 2025

The 10 most active corporate investors in Europe in 2024

The top 10 CVCs all backed at least 9 startups each last year — and one backed more than 30

By Hessa Alabbas
Pro
Barking up the right tree: Could the bioeconomy make Europe money, while solving its biggest climate challenges?
Climate TechAnalysis

April 22, 2025

Barking up the right tree: Could the bioeconomy make Europe money, while solving its biggest climate challenges?

Barking up the right tree: Could the bioeconomy make Europe money, while solving its biggest climate challenges?
Sponsored by ECBF
Wayve ramps up international expansion with Japan testing hub
DeeptechNews

April 22, 2025

Wayve ramps up international expansion with Japan testing hub

By Kai Nicol-Schwarz
Crypto scammers still targeting startup founders and VCs: ‘It’s hard to withstand the lure of easy money’
Venture CapitalAnalysis

April 22, 2025

Crypto scammers still targeting startup founders and VCs: ‘It’s hard to withstand the lure of easy money’

Tether crypto
By Steph Bailey
The ‘breakthrough’ to make cures for neurodegenerative diseases and cancer possible
HealthtechAnalysis

April 22, 2025

The ‘breakthrough’ to make cures for neurodegenerative diseases and cancer possible

picture of cranebio's cofounder Sujaan Das
By Mimi Billing
16 European hardware startups to watch, according to VCs
DeeptechAnalysis

April 22, 2025

16 European hardware startups to watch, according to VCs

A new generation of hardware startups is helping rebuild Europe’s industrial base

By Martin Coulter
Pro
Early-stage Italian VC firm P101 closes €250m investment fund
Venture CapitalNews

April 21, 2025

Early-stage Italian VC firm P101 closes €250m investment fund

By Martin Coulter
Sorry! My Prada's at the cleaners — how to dress tech bro in 2025
Startup LifeAnalysis

April 21, 2025

Sorry! My Prada's at the cleaners — how to dress tech bro in 2025

Mark Zuckerberg
By Éanna Kelly
11 future of compute startups to watch, according to VCs
DeeptechAnalysis

April 21, 2025

11 future of compute startups to watch, according to VCs

Investors from Parkwalk, Amadeus Capital Partners, Apex Ventures, First Momentum Ventures and AlbionVC share the startups they’re watching

By Tom Nugent
Pro